Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cheresh

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imagingA Pfeifer, T Kessler, M Yang, et al.
Cancer Research|June 1, 1989
Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18K Mujoo, T J Kipps, H M Yang, et al.
The Journal of Clinical Investigation|February 1, 1995
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitroL Liaw, M P Skinner, E W Raines, et al.
Cancer Research|October 1, 1990
Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitroW Harel, H Shau, C G Hadley, et al.
Bioorganic & Medicinal Chemistry|October 24, 1998
Design, synthesis and biological evaluation of nonpeptide integrin antagonistsK C Nicolaou, J I Trujillo, B Jandeleit, et al.
Nature Medicine|February 15, 2001
Src deficiency or blockade of Src activity in mice provides cerebral protection following strokeR Paul, Z G Zhang, B P Eliceiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3J C Gutheil, T N Campbell, P R Pierce, et al.
Cancer Research|June 11, 1999
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survivalE Petitclerc, S Strömblad, T L von Schalscha, et al.
Oncogene|October 4, 2011
EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activationM Huang, S Anand, E A Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancerG Gasparini, P C Brooks, E Biganzoli, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imagingA Pfeifer, T Kessler, M Yang, et al.
Cancer Research|June 1, 1989
Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18K Mujoo, T J Kipps, H M Yang, et al.
The Journal of Clinical Investigation|February 1, 1995
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitroL Liaw, M P Skinner, E W Raines, et al.
Cancer Research|October 1, 1990
Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitroW Harel, H Shau, C G Hadley, et al.
Bioorganic & Medicinal Chemistry|October 24, 1998
Design, synthesis and biological evaluation of nonpeptide integrin antagonistsK C Nicolaou, J I Trujillo, B Jandeleit, et al.
Nature Medicine|February 15, 2001
Src deficiency or blockade of Src activity in mice provides cerebral protection following strokeR Paul, Z G Zhang, B P Eliceiri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3J C Gutheil, T N Campbell, P R Pierce, et al.
Cancer Research|June 11, 1999
Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survivalE Petitclerc, S Strömblad, T L von Schalscha, et al.
Oncogene|October 4, 2011
EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activationM Huang, S Anand, E A Murphy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancerG Gasparini, P C Brooks, E Biganzoli, et al.
Pageof 15